BNET Industries
natus medical inc. - All News and Analysis
Natus Medical Incorporated Q3 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator instructions And your first question comes from the line of Ed Shenkan of Needham & Company. Please proceed. Samir Harish – Needham & Company Hi, guys. Thank you for taking the call. This is Samir Harish for Ed. I just wanted to follow up...
Natus Medical, Inc. Q2 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator instructions And your first question is from the line of Erik Schneider, UBS Securities. Erik Schneider – UBS Securities Good morning, gentlemen. Just a quick question for Steve on the gross margin side you laid out the Excel-Tech drag on margins, and higher...
Six Ways to Profit from the Mini-Baby Boom
Option Dragon submits: Population growth is the lifeblood of all civilizations and societies. It is a carried promise of further development and prosperity in a nation. The U.S. is in fact in the midst of a mini baby boom and there are long term opportunities here for the looking. A...
Natus Medical, Inc.: Go baby go!
Everyone loves babies, including Natus Medical, Inc. BABY. Find out why Wall Street is going gah-gah over this company.
Natus Medical Inc. Q1 2008 Earnings Call Transcript
Question-and-Answer Session Operator Operator instructions And your first question comes from Eli Kammerman of Cowen and Company. Please proceed, sir. Eli Kammerman – Cowen & Co. Yes. Thank you and good morning. I've got a couple of questions on neurology, to start. Firstly, you told us...
Natus Medical Announces Proposed Public Offering of Common Stock
SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY), a leading provider of medical devices for the newborn care, hearing and neurology markets, today announced it has filed a preliminary prospectus supplement to its effective shelf registration statement relating to a proposed underwritten offering of 3,500,000 shares of its common stock....
Natus to Raise Approximately $13 Million
Shelf Offering Priced at Close of Market on April 3, 2008 SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY) today announced that it priced an offering to sell 770,000 shares of its common stock at a public offering price of $18.27 per share, which is equal to the closing...
ROTH New York Conference 2006 Additional Presenter Profiles
NEW YORK -- ROTH New York Conference 2006 takes place September 6-7, 2006, at the Westin New York at Times Square. For in-depth information about the event, please visit http://www.rothconference.com/ . Below are profiles from ROTH New York Conference 2006 presenters. Breaking news releases are available at http://www.tradeshownews.com and...
Natus Prices Shelf Offering; Company to Raise Approximately $25 Million
SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY) today announced that it priced an offering to sell 2,300,000 shares of its common stock at a price of $11.63 per share. The shares are being sold under the Company's previously filed shelf registration statement, which was declared effective by the Securities...
Natus Medical Files Shelf Registration Statement; Company to Issue up to $100 Million of New Common Stock
SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY) today announced that it has filed a shelf registration statement with the Securities and Exchange Commission. This registration statement would, upon its being declared effective by the Securities and Exchange Commission, register future sales of up to $100 million of Natus Common...
Natus Medical Inc. Receives ISO9001 Certification
SAN CARLOS, Calif.--BW HealthWire--Aug. 16, 1999-- Natus Medical Inc., today announced that its Quality Management System was recently awarded ISO9001/EN46001 certification by TUV Rheinland Product Safety GmbH, one of the premiere Notified Bodies in Europe. The company also received approval on EC Directive 93/42/EEC Annex II, Article 3,...
Additional Resources
William Blair & Company Initiates Coverage of Natus Medical Incorporated With Market Perform Rating
CHICAGO -- William Blair & Company initiated research coverage of Natus Medical Incorporated (Nasdaq: BABY) ($12.96), a pioneer in the newborn hearing screening market, with a Market Perform rating and Aggressive Growth company profile. Associate Analyst Brian Weinstein estimated the company, which also participates in the newborn care...
Natus to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY) today announced that Jim Hawkins, President and Chief Executive Officer of the Company, will make a presentation at the Lazard Capital Markets 5th Annual Healthcare Conference. The conference is being held at The St. Regis at 2 East 55th Street in New...
Natus Medical Announces Record 2008 Third Quarter Financial Results
* 52% Increase in Net Income Leads to Record Third Quarter Results SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY) today announced financial results for the three and nine months ended September 30, 2008. For the third quarter ended September 30, 2008, revenue increased 45% to...
Natus Medical to Hold 2008 Third Quarter Financial Results Conference Call on October 30
SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY) today announced that the Company intends to release its 2008 third quarter financial results before the market opens on Thursday, October 30, 2008. Natus management will host an investment-community conference call the same day beginning at 11:00 a.m. Eastern Time (8:00 a.m....
Software Application for Bio-logic Navigator Pro AEP System is Now BioMARK
SAN CARLOS, Calif. -- Natus Medical Incorporated today announced the product formerly known as BioMAP Biological Marker of Auditory Processing launched in November 2006 is now known as BioMARK. BioMARK is a software application for the Bio-logic Navigator Pro hearing diagnostic platform that was developed by the Company's Bio-logic division...
Natus Medical to Acquire Products from BrainZ Instruments Limited
SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY) today announced that it has agreed to acquire certain assets from BrainZ Instruments Limited (ASX:BZI). BrainZ, based in Auckland, New Zealand, develops and markets products for the bedside brain monitoring of neonates. Under the purchase agreement, Natus will acquire essentially...
Natus Medical Completes Acquisition of NeuroCom International
SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY) today announced that it has completed its acquisition of privately held NeuroCom International, Inc. NeuroCom, based in Clackamas, Oregon, develops and markets computerized systems for the assessment and rehabilitation of balance and mobility disorders. The acquisition adds to Natus' growth opportunities by...
Natus to Present at the William Blair 2008 Small-Cap Growth Stock Conference
Webcast Available on Company Web Site SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY) today announced that Steven J. Murphy, Vice President Finance and Chief Financial Officer of the Company, will make a presentation at the William Blair 2008 Small-Cap Growth Stock Conference. The conference is being held...
Natus to Present at the 2008 UBS Global Life Sciences Conference
Webcast Available on Company Web Site SAN CARLOS, Calif. -- Natus Medical Incorporated (Nasdaq:BABY) today announced that Jim Hawkins, President and Chief Executive Officer of the Company, will make a presentation at the 2008 UBS Global Life Sciences Conference. The conference is being held at the Grand Hyatt...
Sort byClose
View by Content TypeClose
View by Related Tag Close
- Revenue (Fiscal Year) $118.3M
- Profit (Fiscal Year) $9.7M
- Incorporated: 1987
- CEO: Mr. James B. Hawkins
Natus Medical is a provider of healthcare products used for screening, detection, treatment, monitoring and tracking of medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and certain newborn conditions. Co.'s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.
Competitors
Stock Quote
Board of Directors
Mr. Robert A. Gunst Chairman
Mr. Kenneth E. Ludlum
Mr. Mark D. Michael
Ms. Doris E. Engibous
Mr. James B. Hawkins
Mr. William M. Moore
NAICS Code
Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
Industry Transcripts by Seeking Alpha
-
Healthways, Inc., F1Q09 (Qtr End 11/30/08) Earnings Call Transcript
on Jan 08, 2009about HWAY
-
Prospect Medical Holdings, Inc. Q4 2008 (Qtr End 09/30/08) Earnings Call Transcript
on Jan 08, 2009about PZZ
-
Teleflex Incorporated 2009 Financial Outlook Call Transcript
on Jan 08, 2009about TFX
-
AngioDynamics Inc., F2Q09 (Qtr End 11/30/08) Earnings Call Transcript
on Jan 06, 2009about ANGO
-
Centene Corporation 2009 Financial Guidance Call Transcript
on Dec 19, 2008about CNC